HIV-1 reservoirs in breast milk and challenges to elimination of breast-feeding transmission of HIV-1

Science Translational Medicine

Volumn 4, Issue 143, 2012, Pages

  Van De Perre, Philippe ^a,b,c   Rubbo, Pierre Alain ^a,b,c   Viljoen, Johannes ^d   Nagot, Nicolas ^a,b,c   Tylleskär, Thorkild ^e   Lepage, Philippe ^f   Vendrell, Jean Pierre ^a,b,c   Tuaillon, Edouard ^a,b,c  

^a INSERM   (France)

^b UNIV MONTPELLIER   (France)

^c MONTPELLIER UNIVERSITY HOSPITAL   (France)

^d UNIVERSITY OF KWAZULU NATAL   (South Africa)

^e UNIVERSITY OF BERGEN   (Norway)

^f HOP UNIV DES ENFANTS REINE FABIOLA   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; CD103 ANTIGEN; CD14 ANTIGEN; CELL MARKER; IMMUNOGLOBULIN A; IMMUNOGLOBULIN M; INTERLEUKIN 1BETA; INTERLEUKIN 8; LACTADHERIN; LACTOFERRIN; LAMIVUDINE; LONG ACTING DRUG; LOPINAVIR; NEVIRAPINE; RILPIVIRINE; RITONAVIR; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 4; TRANSFORMING GROWTH FACTOR BETA; VIRUS RNA; ZIDOVUDINE;

B LYMPHOCYTE; BREAST EPITHELIUM; BREAST FEEDING; BREAST MILK; CD3+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; DISEASE CARRIER; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG EFFICACY; EPITHELIUM CELL; FOOD COMPOSITION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN T CELL LEUKEMIA VIRUS INFECTION; INFECTION PREVENTION; INFECTION RISK; LYMPHOCYTE COUNT; MACROPHAGE FUNCTION; MATERNAL CARE; MICROENVIRONMENT; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SECRETORY CELL; SINGLE DRUG DOSE; STEM CELL; T LYMPHOCYTE ACTIVATION; VIRUS PARTICLE; VIRUS RELEASE; VIRUS TRANSMISSION;

BREAST FEEDING; FEMALE; HIV-1; HUMANS; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; MILK, HUMAN;

EID: 84864118940     PISSN: 19466234     EISSN: 19466242     Source Type: Journal    
DOI: 10.1126/scitranslmed.3003327     Document Type: Review

References (150)

1. P. Brandtzaeg, The mucosal immune system and its integration with the mammary glands. J. Pediatr. 156, S8-S15 (2010).
2. L. A. Hanson, Session 1: Feeding and infant development breast-feeding and immune function. Proc. Nutr. Soc. 66, 384-396 (2007).
3. P. Brandtzaeg, F. E. Johansen, Mucosal B cells: Phenotypic characteristics, transcriptional regulation, and homing properties. Immunol. Rev. 206, 32-63 (2005).
4. D. S. Newburg, W. A. Walker, Protection of the neonate by the innate immune system of developing gut and of human milk. Pediatr. Res. 61, 2-8 (2007).
5. J. Akre, Infant feeding. The physiological basis. Bull. World Health Organ. 67, 1-108 (1989).
6. G. Jones, R. W. Steketee, R. E. Black, Z. A. Bhutta, S. S. Morris; Bellagio Child Survival Group, How many child deaths can we prevent this year? Lancet 362, 65-71 (2003).
7. P. Lepage, P. Van de Perre, The immune system of breast milk: Antimicrobial and antiinflammatory properties. Adv. Exp. Med. Biol. 743, 121-137 (2012).
8. L. A. Hanson, The mother-offspring dyad and the immune system. Acta Paediatr. 89, 252-258 (2000).
9. World Health Organization, Towards the Elimination of Mother-to-Child Transmission of HIV. Report of a WHO Technical Consultation (World Health Organization, Geneva, 2010); http://whqlibdoc.who.int/publications/2011/ 9789241501910-eng.pdf.
10. D. Neveu, J. Viljoen, R. M. Bland, N. Nagot, S. Danaviah, A. Coutsoudis, N. C. Rollins, H. M. Coovadia, P. Van de Perre, M. L. Newell, Cumulative exposure to cell-free HIV in breast milk, rather than feeding pattern per se, identifies postnatally infected infants. Clin. Infect. Dis. 52, 819-825 (2011).
11. P. Van de Perre, D. G. Hitimana, P. Lepage, Human immunodeficiency virus antibodies of IgG, IgA, and IgM subclasses in milk of seropositive mothers. J. Pediatr. 113, 1039-1041 (1988).
12. P. Van de Perre, Breast milk transmission of HIV-1. Laboratory and clinical studies. Ann. N. Y. Acad. Sci. 918, 122-127 (2000).
13. P. Van de Perre, A. Simonon, P. Msellati, D. G. Hitimana, D. Vaira, A. Bazubagira, C. Van Goethem, A. M. Stevens, E. Karita, D. Sondag-Thull, F. Dabis, P. Lepage, Postnatal transmission of human immunodeficiency virus type 1 from mother to infant-A prospective cohort study in Kigali, Rwanda. N. Engl. J. Med. 325, 593-598 (1991).
14. K. Liang, X. Gui, Y. Z. Zhang, K. Zhuang, K. Meyers, D. D. Ho, A case series of 104 women infected with HIV-1 via blood transfusion postnatally: High rate of HIV-1 transmission to infants through breast-feeding. J. Infect. Dis. 200, 682-686 (2009).
15. J. H. Humphrey, E. Marinda, K. Mutasa, L. H. Moulton, P. J. Iliff, R. Ntozini, H. Chidawanyika, K. J. Nathoo, N. Tavengwa, A. Jenkins, E. G. Piwoz, P. Van de Perre, B. J. Ward; ZVITAMBO study group, Mother to child transmission of HIV among Zimbabwean women who seroconverted postnatally: Prospective cohort study. BMJ 341, c6580 (2010).
16. Kesho Bora Study Group, Eighteen-month follow-up of HIV-1-infected mothers and their children enrolled in the Kesho Bora Study observational cohorts. J. Acquir. Immune Defic. Syndr. 54, 533-541 (2010).
17. A. Coutsoudis, K. Pillay, E. Spooner, L. Kuhn, H. M. Coovadia, Influence of infant-feeding patterns on early mother-to-child transmission of HIV-1 in Durban, South Africa: A prospective cohort study. South African Vitamin A Study Group. Lancet 354, 471-476 (1999).
18. P. J. Iliff, E. G. Piwoz, N. V. Tavengwa, C. D. Zunguza, E. T. Marinda, K. J. Nathoo, L. H. Moulton, B. J. Ward, J. H. Humphrey; ZVITAMBO study group, Early exclusive breastfeeding reduces the risk of postnatal HIV-1 transmission and increases HIV-free survival. AIDS 19, 699-708 (2005).
19. R. D. Semba, N. Kumwenda, D. R. Hoover, T. E. Taha, T. C. Quinn, L. Mtimavalye, R. J. Biggar, R. Broadhead, P. G. Miotti, L. J. Sokoll, L. van der Hoeven, J. D. Chiphangwi, Human immunodeficiency virus load in breast milk, mastitis, and mother-to-child transmission of human immunodeficiency virus type 1. J. Infect. Dis. 180, 93-98 (1999).
20. K. M. Lunney, P. Iliff, K. Mutasa, R. Ntozini, L. S. Magder, L. H. Moulton, J. H. Humphrey, Associations between breast milk viral load, mastitis, exclusive breast-feeding, and postnatal transmission of HIV. Clin. Infect. Dis. 50, 762-769 (2010).
21. J. M. Brenchley, D. A. Price, T. W. Schacker, T. W. Schacker, T. E. Asher, G. Silvestri, S. Rao, Z. Kazzaz, E. Bornstein, O. Lambotte, D. Altmann, B. R. Blazar, B. Rodriguez, L. Teixeira-Johnson, A. Landay, J. N. Martin, F. M. Hecht, L. J. Picker, M. M. Lederman, S. G. Deeks, D. C. Douek, Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat. Med. 12, 1365-1371 (2006).
22. World Health Organization, HIV and Infant Feeding. Revised Principles and Recommendations. Rapid Advice (World Health Organization, Geneva, 2009); http://whqlibdoc.who.int/publications/2009/9789241598873-eng.pdf.
23. World Health Organization, Antiretroviral Drugs for Treating Pregnant Women and Preventing HIV Infection in Infants. Recommendations for a Public Health Approach (World Health Organization, Geneva, 2010); http://whqlibdoc.who. int/publications/2010/ 9789241599818-eng.pdf.
24. R. L. Shapiro, M. D. Hughes, A. Ogwu, D. Kitch, S. Lockman, C. Moffat, J. Makhema, S. Moyo, I. Thior, K. McIntosh, E. van Widenfelt, J. Leidner, K. Powis, A. Asmelash, E. Tumbare, S. Zwerski, U. Sharma, E. Handelsman, K. Mburu, O. Jayeoba, E. Moko, S. Souda, E. Lubega, M. Akhtar, C. Wester, R. Tuomola, W. Snowden, M. Martinez-Tristani, L. Mazhani, M. Essex, Antiretroviral regimens in pregnancy and breast-feeding in Botswana. N. Engl. J. Med. 362, 2282-2294 (2010).
25. The Kesho Bora Study Group, Triple antiretroviral compared with zidovudine and singledose nevirapine prophylaxis during pregnancy and breastfeeding for prevention of mother-to-child transmission of HIV-1 (Kesho Bora study): a randomised controlled trial. Lancet Infect. Dis. 11, 171-180 (2011).
26. C. A. Peltier, G. F. Ndayisaba, P. Lepage, J. van Griensven, V. Leroy, C. O. Pharm, P. C. Ndimubanzi, O. Courteille, V. Arendt, Breastfeeding with maternal antiretroviral therapy or formula feeding to prevent HIV postnatal mother-to-child transmission in Rwanda. AIDS 23, 2415-2423 (2009).
27. C. S. Chasela, M. G. Hudgens, D. J. Jamieson, D. Kayira, M. C. Hosseinipour, A. P. Kourtis, F. Martinson, G. Tegha, R. J. Knight, Y. I. Ahmed, D. D. Kamwendo, I. F. Hoffman, S. R. Ellington, Z. Kacheche, A. Soko, J. B. Wiener, S. A. Fiscus, P. Kazembe, I. A. Mofolo, M. Chigwenembe, D. S. Sichali, C. M. van der Horst; BAN Study Group, Maternal or infant antiretroviral drugs to reduce HIV-1 transmission. N. Engl. J. Med. 362, 2271-2281 (2010).
28. T. K. Thomas, R. Masaba, C. B. Borkowf, R. Ndivo, C. Zeh, A. Misore, J. Otieno, D. Jamieson, M. C. Thigpen, M. Bulterys, L. Slutsker, K. M. De Cock, P. N. Amornkul, A. E. Greenberg, M. G. Fowler; KiBS Study Team, Triple-antiretroviral prophylaxis to prevent mother-tochild HIV transmission through breastfeeding-The Kisumu Breastfeeding Study, Kenya: A clinical trial. PLoS Med. 8, e1001015 (2011).
29. C. Kilewo, K. Karlsson, M. Ngarina, A. Massawe, E. Lyamuya, R. Lipyoga, G. Msemo, M. Bakari, A. Swai, F. Mhalu, G. Biberfeld, Prevention of mother-to-child transmission of HIV-1 through breastfeeding by treating infants or mothers prophylactically with antiretrovirals in Dar es Salaam, Tanzania: The MITRA and MITRA PLUS studies. Retrovirology 5 (Suppl. 1), O17 (2008).
30. N. I. Kumwenda, D. R. Hoover, L. M. Mofenson, M. C. Thigpen, G. Kafulafula, Q. Li, L. Mipando, K. Nkanaunena, T. Mebrahtu, M. Bulterys, M. G. Fowler, T. E. Taha, Extended antiretroviral prophylaxis to reduce breast-milk HIV-1 transmission. N. Engl. J. Med. 359, 119-129 (2008).
31. Six Week Extended-Dose Nevirapine (SWEN) Study Team, A. Bedri, B. Gudetta, A. Isehak, S. Kumbi, S. Lulseged, Y. Mengistu, A. V. Bhore, R. Bhosale, V. Varadhrajan, N. Gupte, J. Sastry, N. Suryavanshi, S. Tripathy, F. Mmiro, M. Mubiru, C. Onyango, A. Taylor, P. Musoke, C. Nakabiito, A. Abashawl, R. Adamu, G. Antelman, R. C. Bollinger, P. Bright, M. A. Chaudhary, J. Coberly, L. Guay, M. G. Fowler, A. Gupta, E. Hassen, J. B. Jackson, L. H. Moulton, U. Nayak, S. B. Omer, L. Propper, M. Ram, V. Rexroad, A. J. Ruff, A. Shankar, S. Zwerski, Extended-dose nevirapine to 6 weeks of age for infants to prevent HIV transmission via breastfeeding in Ethiopia, India, and Uganda: An analysis of three randomised controlled trials. Lancet 372, 300-313 (2008).
32. H. M. Coovadia, E. R. Brown, M. G. Fowler, T. Chipato, D. Moodley, K. Manji, P. Musoke, L. Stranix-Chibanda, V. Chetty, W. Fawzi, C. Nakabiito, L. Msweli, R. Kisenge, L. Guay, A. Mwatha, D. J. Lynn, S. H. Eshleman, P. Richardson, K. George, P. Andrew, L. M. Mofenson, S. Zwerski, Y. Maldonado; HPTN 046 protocol team, Efficacy and safety of an extended nevirapine regimen in infant children of breastfeeding mothers with HIV-1 infection for prevention of postnatal HIV-1 transmission (HPTN 046): A randomised, double-blind, placebo-controlled trial. Lancet 379, 221-228 (2012).
33. G. Smolenski, S. Haines, F. Y. Kwan, J. Bond, V. Farr, S. R. Davis, K. Stelwagen, T. T. Wheeler, Characterisation of host defence proteins in milk using a proteomic approach. J. Proteome Res. 6, 207-215 (2007).
34. H. J. Hosea Blewett, M. C. Cicalo, C. D. Holland, C. J. Field, The immunological components of human milk. Adv. Food Nutr. Res. 54, 45-80 (2008).
35. P. Brandtzaeg, Mucosal immunity: Integration between mother and the breast-fed infant. Vaccine 21, 3382-3388 (2003).
36. P. Van de Perre, Transfer of antibody via mother's milk. Vaccine 21, 3374-3376 (2003).
37. P. Valenti, G. Antonini, Lactoferrin: An important host defence against microbial and viral attack. Cell. Mol. Life Sci. 62, 2576-2587 (2005).
38. R. T. Ellison III, T. J. Giehl, Killing of gram-negative bacteria by lactoferrin and lysozyme. J. Clin. Invest. 88, 1080-1091 (1991).
39. J. B. German, C. J. Dillard, Composition, structure and absorption of milk lipids: A source of energy, fat-soluble nutrients and bioactive molecules. Crit. Rev. Food Sci. Nutr. 46, 57-92 (2006).
40. J. Buer, R. Balling, Mice, microbes and models of infection. Nat. Rev. Genet. 4, 195-205 (2003).
41. E. LeBouder, J. E. Rey-Nores, N. K. Rushmere, M. Grigorov, S. D. Lawn, M. Affolter, G. E. Griffin, P. Ferrara, E. J. Schiffrin, B. P. Morgan, M. O. Labéta, Soluble forms of Toll-like receptor (TLR)2 capable of modulating TLR2 signaling are present in human plasma and breast milk. J. Immunol. 171, 6680-6689 (2003).
42. R. J. Ulevitch, J. C. Mathison, J. da Silva Correia, Innate immune responses during infection. Vaccine 22 (Suppl. 1), S25-S30 (2004).
43. H. P. Jia, T. Starner, M. Ackermann, P. Kirby, B. F. Tack, P. B. McCray Jr., Abundant human β-defensin-1 expression in milk and mammary gland epithelium. J. Pediatr. 138, 109-112 (2001).
44. A. S. Kvistgaard, L. T. Pallesen, C. F. Arias, S. Lopez, T. E. Petersen, C. W. Heegaard, J. T. Rasmussen, Inhibitory effects of human and bovine milk constituents on rotavirus infections. J. Dairy Sci. 87, 4088-4096 (2004).
45. S. M. Wahl, T. B. McNeely, E. N. Janoff, D. Shugars, P. Worley, C. Tucker, J. M. Orenstein, Secretory leukocyte protease inhibitor (SLPI) in mucosal fluids inhibits HIV-I. Oral Dis. 3 (Suppl. 1), S64-S69 (1997).
46. M. Ogundele, Role and significance of the complement system in mucosal immunity: Particular reference to the human breast milk complement. Immunol. Cell Biol. 79, 1-10 (2001).
47. N. N. Nanthakumar, R. D. Fusunyan, I. Sanderson, W. A. Walker, Inflammation in the developing human intestine: A possible pathophysiologic contribution to necrotizing enterocolitis. Proc. Natl. Acad. Sci. U.S.A. 97, 6043-6048 (2000).
48. P. W. Lin, B. J. Stoll, Necrotising enterocolitis. Lancet 368, 1271-1283 (2006).
49. L. Haversen, B. G. Ohlsson, M. Hahn-Soric, L. A. Hanson, I. Mattsby-Baltzer, Lactoferrin down-regulates the LPS-induced cytokine production in monocytic cells via NF-κB. Cell. Immunol. 220, 83-95 (2002).
50. W. Walker, Breast milk as the gold standard for protective nutrients. J. Pediatr. 156, S3-S7 (2010).
51. E. C. Claud, T. Savidge, W. A. Walker, Modulation of human intestinal epithelial cell IL-8 secretion by human milk factors. Pediatr. Res. 53, 419-425 (2003).
52. J. E. Arsenault, A. L. Webb, I. N. Koulinska, S. Aboud, W. W. Fawzi, E. Villamor, Association between breast milk erythropoietin and reduced risk of mother-to-child transmission of HIV. J. Infect. Dis. 202, 370-373 (2010).
53. L. J. Martin, J. G. Woo, S. R. Geraghty, M. Ataye, B. S. Davidson, W. Banach, L. M. Dolan, G. M. Ruiz-Palacios, A. L. Morrow, Adiponectin is present in human milk and is associated with maternal factors. Am. J. Clin. Nutr. 83, 1106-1111 (2006).
54. G. Petitjean, P. Becquart, E. Tuaillon, Y. Al Tabaa, D. Valea, M. F. Huguet, N. Meda, P. Van de Perre, J. P. Vendrell, Isolation and characterization of HIV-1-infected resting CD4+ T lymphocytes in breast milk. J. Clin. Virol. 39, 1-8 (2007).
55. M. D. Cregan, Y. Fan, A. Appelbee, M. L. Brown, B. Klopcic, J. Koppen, L. R. Mitoulas, K. M. Piper, M. A. Choolani, Y. S. Chong, P. E. Hartmann, Identification of nestin-positive putative mammary stem cells in human breastmilk. Cell Tissue Res. 329, 129-136 (2007).
56. Y. Fan, Y. S. Chong, M. A. Choolani, M. D. Cregan, J. K. Y. Chan, Unravelling the mystery of stem/progenitor cells in human breast milk. PLoS One 5, e14421 (2010).
57. A. P. Kourtis, C. C. Ibegbu, R. Theiler, Y. X. Xu, P. Bansil, D. J. Jamieson, M. Lindsay, S. Butera, A. Duerr, Breast milk CD4+ T cells express high levels of C chemokine receptor 5 and CXC chemokine receptor 4 and are preserved in HIV-infected mothers receiving highly active antiretroviral therapy. J. Infect. Dis. 195, 965-972 (2007).
58. S. R. Permar, H. H. Kang, A. Carville, A. B. Wilks, K. G. Mansfield, S. S. Rao, N. L. Letvin, Preservation of memory CD4+ T lymphocytes in breast milk of lactating rhesus monkeys during acute simian immunodeficiency virus infection. J. Infect. Dis. 201, 302-310 (2010).
59. D. Valea, E. Tuaillon, Y. Al Tabaa, F. Rouet, P. A. Rubbo, N. Meda, V. Foulongne, K. Bollore, P. Van de Perre, J. P. Vendrell, CD4+ T cells spontaneously producing human immunodeficiency virus type I in breast milk from women with or without antiretroviral drugs. Retrovirology 8, 34 (2011).
60. A. Bertotto, R. Gerli, G. Fabietti, S. Crupi, C. Arcangeli, F. Scalise, R. Vaccaro, Human breast milk T lymphocytes display the phenotype and functional characteristics of memory T cells. Eur. J. Immunol. 20, 1877-1880 (1990).
61. E. Tuaillon, D. Valea, P. Becquart, Y. Al Tabaa, N. Meda, K. Bolloré, P. Van de Perre, J. P. Vendrell, Human milk-derived B cells: A highly activated switched memory cell population primed to secrete antibodies. J. Immunol. 182, 7155-7162 (2009).
62. R. A. Rivas, A. A. el-Mohandes, I. M. Katona, Mononuclear phagocytic cells in human milk: HLA-DR and FcγR ligand expression. Biol. Neonate 66, 195-204 (1994).
63. D. P. Wirt, L. T. Adkins, K. H. Palkowetz, F. C. Schmalstieg, A. S. Goldman, Activated and memory T lymphocytes in human milk. Cytometry 13, 282-290 (1992).
64. S. Sabbaj, M. K. Ghosh, B. H. Edwards, R. Leeth, W. D. Decker, P. A. Goepfert, G. M. Aldrovandi, Breast milk-derived antigen-specific CD8+ T cells: An extralymphoid effector memory cell population in humans. J. Immunol. 174, 2951-2956 (2005).
65. S. Sabbaj, B. H. Edwards, M. K. Ghosh, K. Semrau, S. Cheelo, D. M. Thea, L. Kuhn, G. D. Ritter, M. J. Mulligan, P. A. Goepfert, G. M. Aldrovandi, Human immunodeficiency virus-specific CD8+ T cells in human breast milk. J. Virol. 76, 7365-7373 (2002).
66. B. L. Lohman, J. Slyker, D. Mbori-Ngacha, R. Bosire, C. Farquhar, E. Obimbo, P. Otieno, R. Nduati, S. Rowland-Jones, G. John-Stewart, Prevalence and magnitude of human immunodeficiency virus (HIV) type 1-specific lymphocyte responses in breast milk from HIV-1-seropositive women. J. Infect. Dis. 188, 1666-1674 (2003).
67. J. Zizka, J. Hrdý, R. Lodinová- Zádníková, I. Kocourková, O. Novotná, I. Sterzl, L. Prokesová, Effect of breast milk of healthy and allergic mothers on in vitro stimulation of cord blood lymphocytes. Pediatr. Allergy Immunol. 18, 486-494 (2007).
68. J. Huehn, K. Siegmund, J. C. Lehmann, C. Siewert, U. Haubold, M. Feuerer, G. F. Debes, J. Lauber, O. Frey, G. K. Przybylski, U. Niesner, M. de la Rosa, C. A. Schmidt, R. Bräuer, J. Buer, A. Scheffold, A. Hamann, Developmental stage, phenotype, and migration distinguish naive-and effector/memory-like CD4+ regulatory T cells. J. Exp. Med. 199, 303-313 (2004).
69. G. L. Stephens, J. Andersson, E. M. Shevach, Distinct subsets of FoxP3+ regulatory T cells participate in the control of immune responses. J. Immunol. 178, 6901-6911 (2007).
70. D. Zhao, C. Zhang, T. Yi, C. L. Lin, I. Todorov, F. Kandeel, S. Forman, D. Zeng, In vivo-activated CD103+CD4+ regulatory T cells ameliorate ongoing chronic graft-versus-host disease. Blood 112, 2129-2138 (2008).
71. H. W. Lim, H. E. Broxmeyer, C. H. Kim, Regulation of trafficking receptor expression in human forkhead box P3+ regulatory T cells. J. Immunol. 177, 840-851 (2006).
72. C. Cicala, E. Martinelli, J. P. McNally, D. J. Goode, R. Gopaul, J. Hiatt, K. Jelicic, S. Kottilil, K. Macleod, A. O'Shea, N. Patel, D. Van Ryk, D. Wei, M. Pascuccio, L. Yi, L. McKinnon, P. Izulla, J. Kimani, R. Kaul, A. S. Fauci, J. Arthos, The integrin α4β7 forms a complex with cell-surface CD4 and defines a T-cell subset that is highly susceptible to infection by HIV-1. Proc. Natl. Acad. Sci. U.S.A. 106, 20877-20882 (2009).
73. F. Nawaz, C. Cicala, D. Van Ryk, K. E. Block, K. Jelicic, J. P. McNally, O. Ogundare, M. Pascuccio, N. Patel, D. Wei, A. S. Fauci, J. Arthos, The genotype of early-transmitting HIV gp120s promotes α4β7-reactivity, revealing α4β7+/CD4+ T cells as key targets in mucosal transmission. PLoS Pathog. 7, e1001301 (2011).
74. M. Ichikawa, M. Sugita, M. Takahashi, M. Satomi, T. Takeshita, T. Araki, H. Takahashi, Breast milk macrophages spontaneously produce granulocyte- macrophage colony-stimulating factor and differentiate into dendritic cells in the presence of exogenous interleukin-4 alone. Immunology 108, 189-195 (2003).
75. E. A. Weaver, R. M. Goldblum, C. P. Davis, A. S. Goldman, Enhanced immunoglobulin A release from human colostral cells during phagocytosis. Infect. Immun. 34, 498-502 (1981).
76. J. Pitt, The milk mononuclear phagocyte. Pediatrics 64, 745-759 (1979).
77. J. M. Brenchley, D. C. Douek, HIV infection and the gastrointestinal immune system. Mucosal Immunol. 1, 23-30 (2008).
78. P. A. Rubbo, E. Tuaillon, K. Bolloré, V. Foulongne, A. Bourdin, N. Nagot, P. Van de Perre, C. Desgranges, D. Israël-Biet, J. P. Vendrell, The potential impact of CD4+ T cell activation and enhanced Th1/Th2 cytokine ratio on HIV-1 secretion in the lungs of individuals with advanced AIDS and active pulmonary infection. Clin. Immunol. 139, 142-154 (2011).
79. J. Walter, M. K. Ghosh, L. Kuhn, K. Semrau, M. Sinkala, C. Kankasa, D. M. Thea, G. M. Aldrovandi, High concentrations of interleukin 15 in breast milk are associated with protection against postnatal HIV transmission. J. Infect. Dis. 200, 1498-1502 (2009).
80. J. Walter, L. Kuhn, M. K. Ghosh, C. Kankasa, K. Semrau, M. Sinkala, M. Mwiya, D. M. Thea, G. M. Aldrovandi, Low and undetectable breast milk interleukin-7 concentrations are associated with reduced risk of postnatal HIV transmission. J. Acquir. Immune Defic. Syndr. 46, 200-207 (2007).
81. L. Kasonka, M. Makasa, T. Marshall, M. Chisenga, M. Sinkala, C. Chintu, C. Kaseba, F. Kasolo, R. Gitau, A. Tomkins, S. Murray, S. Filteau, Risk factors for subclinical mastitis among HIV-infected and uninfected women in Lusaka, Zambia. Paediatr. Perinat. Epidemiol. 20, 379-391 (2006).
82. S. Kantarci, I. N. Koulinska, S. Aboud, W. W. Fawzi, E. Villamor, Subclinical mastitis, cell-associated HIV-1 shedding in breast milk, and breast-feeding transmission of HIV-1. J. Acquir. Immune Defic. Syndr. 46, 651-654 (2007).
83. A. Toniolo, C. Serra, P. G. Conaldi, F. Basolo, V. Falcone, A. Dolei, Productive HIV-1 infection of normal human mammary epithelial cells. AIDS 9, 859-866 (1995).
84. S. M. Dorosko, R. I. Connor, Primary human mammary epithelial cells endocytose HIV-1 and facilitate viral infection of CD4+ T lymphocytes. J. Virol. 84, 10533-10542 (2010).
85. C. M. Okeoma, A. L. Huegel, J. Lingappa, M. D. Feldman, S. R. Ross, APOBEC3 proteins expressed in mammary epithelial cells are packaged into retroviruses and can restrict transmission of milk-borne virions. Cell Host Microbe 8, 534-543 (2010).
86. E. Saeland, M. A. de Jong, A. A. Nabatov, H. Kalay, T. B. Geijtenbeek, Y. van Kooyk, MUC1 in human milk blocks transmission of human immunodeficiency virus from dendritic cells to T cells. Mol. Immunol. 46, 2309-2316 (2009).
87. E. Castelletti, S. Lo Caputo, L. Kuhn, M. Borelli, J. Gajardo, M. Sinkala, D. Trabattoni, C. Kankasa, E. Lauri, A. Clivio, L. Piacentini, D. H. Bray, G. M. Aldrovandi, D. M. Thea, F. Veas, M. Nebuloni, F. Mazzotta, M. Clerici, The mucosae-associated epithelial chemokine (MEC/CCL28) modulates immunity in HIV infection. PLoS One 2, e969 (2007).
88. A. S. Perelson, A. U. Neumann, M. Markowitz, J. M. Leonard, D. D. Ho, HIV-1 dynamics in vivo: Virion clearance rate, infected cell life-span, and viral generation time. Science 271, 1582-1586 (1996).
89. L. Rong, A. S. Perelson, Asymmetric division of activated latently infected cells may explain the decay kinetics of the HIV-1 latent reservoir and intermittent viral blips. Math. Biosci. 217, 77-87 (2009).
90. D. Finzi, J. Blankson, J. D. Siliciano, J. B. Margolick, K. Chadwick, T. Pierson, K. Smith, J. Lisziewicz, F. Lori, C. Flexner, T. C. Quinn, R. E. Chaisson, E. Rosenberg, B. Walker, S. Gange, J. Gallant, R. F. Siliciano, Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy. Nat. Med. 5, 512-517 (1999).
91. J. M. Fondere, G. Petitjean, M. F. Huguet, S. L. Sahli, V. Baillat, A. Macura-Biegun, P. Becquart, J. Reynes, J. P. Vendrell, Human immunodeficiency virus type 1 (HIV-1) antigen secretion by latently infected resting CD4+ T lymphocytes from HIV-1-infected individuals. J. Virol. 78, 10536-10542 (2004).
92. M. Hermankova, J. D. Siliciano, Y. Zhou, D. Monie, K. Chadwick, J. B. Margolick, T. C. Quinn, R. F. Siliciano, Analysis of human immunodeficiency virus type 1 gene expression in latently infected resting CD4+ T lymphocytes in vivo. J. Virol. 77, 7383-7392 (2003).
93. P. Becquart, G. Petitjean, Y. Al Tabaa,D. Valéa, M. F.Huguet, E. Tuaillon,N.Meda, J. P. Vendrell, P. Van de Perre, Detection of a large T-cell reservoir able to replicate HIV-1 actively in breast milk. AIDS 20, 1453-1455 (2006).
94. G. Petitjean, P. Becquart, Y. Al Tabaa, J. P. Vendrell, P. Van de Perre, Compartment-specific HIV-1 resting T-cell reservoirs. AIDS 20, 1338-1340 (2006).
95. P. Becquart, V. Courgnaud, J. Willumsen, P. Van de Perre, Diversity of HIV-1 RNA and DNA in breast milk from HIV-1-infected mothers. Virology 363, 256-260 (2007).
96. H. E. Rudloff, F. C. Schmalstieg Jr., K. H. Palkowetz, E. J. Paszkiewicz, A. S. Goldman, Interleukin-6 in human milk. J. Reprod. Immunol. 23, 13-20 (1993).
97. D. Gazzolo, G. Monego, V. Corvino, M. Bruschettini, P. Bruschettini, G. Zelano, F. Michetti, Human milk contains S100B protein. Biochim. Biophys. Acta 1619, 209-212 (2003).
98. C. Ryckman, G. A. Robichaud, J. Roy, R. Cantin, M. J. Tremblay, P. A. Tessier, HIV-1 transcription and virus production are both accentuated by the proinflammatory myeloid-related proteins in human CD4+ T lymphocytes. J. Immunol. 169, 3307-3313 (2002).
99. G. Petitjean, Y. Al Tabaa, E. Tuaillon, C. Mettling, V. Baillat, J. Reynes, M. Segondy, J. P. Vendrell, Unintegrated HIV-1 provides an inducible and functional reservoir in untreated and highly active antiretroviral therapy-treated patients. Retrovirology 4, 60 (2007).
100. T. W. Chun, J. S. Justement, S. Moir, C. W. Hallahan, J. Maenza, J. I. Mullins, A. C. Collier, L. Corey, A. S. Fauci, Decay of the HIV reservoir in patients receiving antiretroviral therapy for extended periods: Implications for eradication of virus. J. Infect. Dis. 195, 1762-1764 (2007).
101. P. Becquart, N. Chomont, P. Roques, A. Ayouba, M. D. Kazatchkine, L. Bélec, H. Hocini, Compartmentalization of HIV-1 between breast milk and blood of HIV-infected mothers. Virology 300, 109-117 (2002).
102. R. L. Shapiro, T. Ndung'u, S. Lockman, L. M. Smeaton, I. Thior, C.Wester, L. Stevens, G. Sebetso, S. Gaseitsiwe, T. Peter, M. Essex, Highly active antiretroviral therapy started during pregnancy or postpartum suppresses HIV-1 RNA, but not DNA, in breast milk. J. Infect. Dis. 192, 713-719 (2005).
103. D. A. Lehman, M. H. Chung, G. C. John-Stewart, B. A. Richardson, J. Kiarie, J. Kinuthia, J. Overbaugh, HIV-1 persists in breast milk cells despite antiretroviral treatment to prevent mother-to-child transmission. AIDS 22, 1475-1485 (2008).
104. O. Manigart, M. Crepin, V. Leroy, N. Meda, D. Valea, E. N. Janoff, F. Rouet, L. Dequae-Merchadoux, F. Dabis, C. Rouzioux, P. Van de Perre; Diminution de la Transmission Mere-Enfant Study Group, Effect of perinatal zidovudine prophylaxis on the evolution of cell-free HIV-1 RNA in breast milk and on postnatal transmission. J. Infect. Dis. 190, 1422-1428 (2004).
105. Y. Yagi, E. Watanabe, E. Watari, E. Shinya, M. Satomi, T. Takeshita, H. Takahashi, Inhibition of DC-SIGN-mediated transmission of human immunodeficiency virus type 1 by Toll-like receptor 3 signalling in breast milk macrophages. Immunology 130, 597-607 (2010).
106. M. Stevenson, HIV-1 pathogenesis. Nat. Med. 9, 853-860 (2003).
107. O. Narayan, L. C. Cork, Lentiviral diseases of sheep and goats: Chronic pneumonia leukoencephalomyelitis and arthritis. Rev. Infect. Dis. 7, 89-98 (1985).
108. H. Takeushi, M. Takahashi, Y. Norose, T. Takeshita, Y. Fukunaga, H. Takahashi, Transformation of breast milk macrophages by HTLV-I: Implications for HTLV-I transmission via breastfeeding. Biomed. Res. 31, 53-61 (2010).
109. C. M. Rousseau, R. W. Nduati, B. A. Richardson, M. S. Steele, G. C. John-Stewart, D. A. Mbori-Ngacha, J. K. Kreiss, J. Overbaugh, Longitudinal analysis of human immunodeficiency virus type 1 RNA in breast milk and of its relationship to infant infection and maternal disease. J. Infect. Dis. 187, 741-747 (2003).
110. K. Pillay, A. Coutsoudis, D. York, L. Kuhn, H. M. Coovadia, Cell-free virus in breast milk of HIV-1-seropositive women. J. Acquir. Immune Defic. Syndr. 24, 330-336 (2000).
111. P. Lewis, R. Nduati, J. K. Kreiss, G. C. John, B. A. Richardson, D. Mbori-Ngacha, J. Ndinya-Achola, J. Overbaugh, Cell-free human immunodeficiency virus type 1 in breast milk. J. Infect. Dis. 177, 34-39 (1998).
112. I. F. Hoffman, F. E. Martinson, P. W. Stewart, D. A. Chilongozi, S. Y. Leu, P. N. Kazembe, T. Banda, W. Dzinyemba, P. Joshi, M. S. Cohen, S. A. Fiscus, Human immunodeficiency virus type 1 RNA in breast-milk components. J. Infect. Dis. 188, 1209-1212 (2003).
113. P. Becquart, V. Foulongne, J. Willumsen, C. Rouzioux, M. Segondy, P. Van de Perre, Quantitation of HIV-1 RNA in breast milk by real time PCR. J. Virol. Methods 133, 109-111 (2006).
114. J. F. Willumsen, S. M. Filteau, A. Coutsoudis, K. E. Uebel, M. L. Newell, A. M. Tomkins, Subclinical mastitis as a risk factor for mother-infant HIV transmission. Adv. Exp. Med. Biol. 478, 211-223 (2000).
115. G. C. John, R. W. Nduati, D. A. Mbori-Ngacha, B. A. Richardson, D. Panteleeff, A. Mwatha, J. Overbaugh, J. Bwayo, J. O. Ndinya-Achola, J. K. Kreiss, Correlates of mother-to-child human immunodeficiency virus type 1 (HIV-1) transmission: Association with maternal plasma HIV-1 RNA load, genital HIV-1 DNA shedding, and breast infections. J. Infect. Dis. 183, 206-212 (2001).
116. S. Gantt, J. Carlsson, L. Heath, M. E. Bull, A. K. Shetty, J. Mutsvangwa, G. Musingwini, G. Woelk, L. S. Zijenah, D. A. Katzenstein, J. I. Mullins, L. M. Frenkel, Genetic analyses of HIV-1 env sequences demonstrate limited compartmentalization in breast milk and suggest viral replication within the breast that increases with mastitis. J. Virol. 84, 10812-10819 (2010).
117. D. A. Lehman, C. Farquhar, Biological mechanisms of vertical human immunodeficiency virus (HIV-1) transmission. Rev. Med. Virol. 17, 381-403 (2007).
118. H. M. Coovadia, N. C. Rollins, R. M. Bland, K. Little, A. Coutsoudis, M. L. Bennish, M. L. Newell, Mother-to-child transmission of HIV-1 infection during exclusive breastfeeding in the first 6 months of life: An intervention cohort study. Lancet 369, 1107-1116 (2007).
119. P. Van de Perre, A. Simonon, D. G. Hitimana, F. Dabis, P. Msellati, B. Mukamabano, J. B. Butera, C. Van Goethem, E. Karita, P. Lepage, Infective and anti-infective properties of breastmilk from HIV-1-infected women. Lancet 341, 914-918 (1993).
120. I. N. Koulinska, E. Villamor, B. Chaplin, G. Msamanga, W. Fawzi, B. Renjifo, M. Essex, Transmission of cell-free and cell-associated HIV-1 through breast-feeding. J. Acquir. Immune Defic. Syndr. 41, 93-99 (2006).
121. C. M. Rousseau, R. W. Nduati, B. A. Richardson, G. C. John-Stewart, D. A. Mbori-Ngacha, J. K. Kreiss, J. Overbaugh, Association of levels of HIV-1-infected breast milk cells and risk of mother-to-child transmission. J. Infect. Dis. 190, 1880-1888 (2004).
122. R. M. Ruprecht, T. W. Baba, V. Liska, S. Ayehunie, J. Andersen, D. C. Montefiori, A. Trichel, M. Murphy-Corb, L. Martin, T. A. Rizvi, B. J. Bernacky, S. J. Buchl, M. Keeling, Oral SIV, SHIV, and HIV type 1 infection. AIDS Res. Hum. Retroviruses 14 (Suppl. 1), S97-S103 (1998).
123. K. Yamanouchi, K. Kinoshita, R. Moriuchi, S. Katamine, T. Amagasaki, S. Ikeda, M. Ichimaru, T. Miyamoto, S. Hino, Oral transmission of human T-cell leukemia virus type-I into a common marmoset (Callithrix jacchus) as an experimental model for milk-borne transmission. Jpn. J. Cancer Res. 76, 481-487 (1985).
124. S. Hirose, S. Kotani, Y. Uemura, M. Fujishita, H. Taguchi, Y. Ohtsuki, I. Miyoshi, Milkborne transmission of human T-cell leukemia virus type I in rabbits. Virology 162, 487-489 (1988).
125. T. Thomas, R. Masaba, R. Ndivo, C. Zeh, C. Borkowf, M. Thigpen, K. De Cock, P. Amornkul, A. Greenberg, M. Fowler, Kisumu Breastfeeding Study Team, Prevention of mother-tochild transmission of HIV-1 among breastfeeding mothers using HAART: The Kisumu Breastfeeding Study, Kisumu, Kenya, 2003-2007, paper presented at the 15th Conference on Retroviruses and Opportunistic Infections, Boston, MA, 3 to 6 February 2008.
126. D. S. Dimitrov, R. L. Willey, H. Sato, L. J. Chang, R. Blumenthal, M. A. Martin, Quantitation of human immunodeficiency virus type 1 infection kinetics. J. Virol. 67, 2182-2190 (1993).
127. S. S. Ogra, P. L. Ogra, Immunologic aspects of human colostrum and milk. I. Distribution characteristics and concentrations of immunoglobulins at different times after the onset of lactation. J. Pediatr. 92, 546-549 (1978).
128. A. Alfsen, H. Yu, A. Magérus-Chatinet, A. Schmitt, M. Bomsel, HIV-1-infected blood mononuclear cells form an integrin-and agrin-dependent viral synapse to induce efficient HIV-1 transcytosis across epithelial cell monolayer. Mol. Biol. Cell 16, 4267-4279 (2005).
129. M. Bomsel, V. David, Mucosal gatekeepers: Selecting HIV viruses for early infection. Nat. Med. 8, 114-116 (2002).
130. M. Nejmeddine, A. L. Barnard, Y. Tanaka, G. P. Taylor, C. R. Bangham, Human T-lymphotropic virus, type 1, tax protein triggers microtubule reorientation in the virological synapse. J. Biol. Chem. 280, 29653-29660 (2005).
131. E. A. Eugenin, P. J. Gaskill, J. W. Berman, Tunneling nanotubes (TNT) are induced by HIV-infection of macrophages: A potential mechanism for intercellular HIV trafficking. Cell. Immunol. 254, 142-148 (2009).
132. S. Sowinski, C. Jolly, O. Berninghausen, M. A. Purbhoo, A. Chauveau, K. Kohler, S. Oddos, P. Eissmann, F. M. Brodsky, C. Hopkins, B. Onfelt, Q. Sattentau, D. M. Davis, Membrane nanotubes physically connect T cells over long distances presenting a novel route for HIV-1 transmission. Nat. Cell Biol. 10, 211-219 (2008).
133. D. Rudnicka, J. Feldmann, F. Porrot, S. Wietgrefe, S. Guadagnini, M. C. Prévost, J. Estaquier, A. T. Haase, N. Sol-Foulon, O. Schwartz, Simultaneous cell-to-cell transmission of human immunodeficiency virus to multiple targets through polysynapses. J. Virol. 83, 6234-6246 (2009).
134. M. A. Lyimo, A. L. Howell, E. Balandya, S. K. Eszterhas, R. I. Connor, Innate factors in human breast milk inhibit cell-free HIV-1 but not
135. S. Gantt, J. Carlsson, A. K. Shetty, K. D. Seidel, X. Qin, J. Mutsvangwa, G. Musingwini, G. Woelk, L. S. Zijenah, D. A. Katzenstein, L. M. Frenkel, Cytomegalovirus and Epstein-Barr virus in breast milk are associated with HIV-1 shedding but not with mastitis. AIDS 22, 1453-1460 (2008).
136. J. Lidstrom, L. Guay, P. Musoke, M. Owor, C. Onyango-Makubi, J. D. Church, S. B. Omer, J. B. Jackson, S. H. Eshelman, Multi-class resistance arises frequently in HIV-infected breastfeeding infants whose mothers initiate HAART postpartum, paper presented at the 17th Conference on Retroviruses and Opportunistic Infections, San Francisco, CA, 16 to 19 February 2010.
137. J. Fogel, Q. Li, T. E. Taha, D. R. Hoover, N. I. Kumwenda, L. M. Mofenson, J. J. Kumwenda, M. G. Fowler, M. C. Thigpen, S. H. Eshleman, Initiation of antiretroviral treatment in women after delivery can induce multiclass drug resistance in breastfeeding HIV-infected infants. Clin. Infect. Dis. 52, 1069-1076 (2011).
138. C. Zeh, P. J. Weidle, L. Nafisa, H. M. Lwamba, J. Okonji, E. Anyango, P. Bondo, R. Masaba, M. G. Fowler, J. N. Nkengasong, M. C. Thigpen, T. Thomas, HIV-1 drug resistance emergence among breastfeeding infants born to HIV-infected mothers during a single-arm trial of triple-antiretroviral prophylaxis for prevention of mother-to-child transmission: A secondary analysis. PLoS Med. 8, e1000430 (2011).
139. N. L. Rezk, N. White, A. S. Bridges, M. F. Abdel-Megeed, T. M. Mohamed, S. S. Moselhy, A. D. Kashuba, Studies on antiretroviral drug concentrations in breast milk: Validation of a liquid chromatography-tandem mass spectrometric method for the determination of 7 anti-human immunodeficiency virus medications. Ther. Drug Monit. 30, 611-619 (2008).
140. R. L. Shapiro, D. T. Holland, E. Capparelli, S. Lockman, I. Thior, C. Wester, L. Stevens, T. Peter, M. Essex, J. D. Connor, M. Mirochnick, Antiretroviral concentrations in breast-feeding infants of women in Botswana receiving antiretroviral treatment. J. Infect. Dis. 192, 720-727 (2005).
141. C. Kilewo, K. Karlsson, A. Massawe, E. Lyamuya, A. Swai, F. Mhalu, G. Biberfeld; Mitra Study Team, Prevention of mother-to-child transmission of HIV-1 through breast-feeding by treating infants prophylactically with lamivudine in Dar es Salaam, Tanzania: The Mitra study. J. Acquir. Immune Defic. Syndr. 48, 315-323 (2008).
142. J. McIntyre, Strategies to prevent mother-to-child transmission of HIV. Curr. Opin. Infect. Dis. 19, 33-38 (2006).
143. A. Violari, M. F. Cotton, D. M. Gibb, A. G. Babiker, J. Steyn, S. A. Madhi, P. Jean-Philippe, J. A. McIntyre; CHER Study Team, Early antiretroviral therapy and mortality among HIV-infected infants. N. Engl. J. Med. 359, 2233-2244 (2008).
144. E. G. Chadwick, E. V. Capparelli, R. Yogev, J. A. Pinto, B. Robbins, J. H. Rodman, J. Chen, P. Palumbo, L. Serchuck, E. Smith, M. Hughes; P1030 team, Pharmacokinetics, safety and efficacy of lopinavir/ritonavir in infants less than 6 months of age: 24 week results. AIDS 22, 249-255 (2008).
145. G. van ' t Klooster, E. Hoeben, H. Borghys, A. Looszova, M. P. Bouche, F. van Velsen, L. Baert, Pharmacokinetics and disposition of rilpivirine (TMC278) nanosuspension as a long-acting injectable antiretroviral formulation. Antimicrob. Agents Chemother. 54, 2042-2050 (2010).
146. G. van't Klooster, R. Verloes, L. Baert, F. van Velsen, M. P. Bouche, K. Spittaels, J. Leempoels, P. Williams, G. Kraus, P. Wigerinck, Long-acting TMC278, a parenteral depot formulation delivering therapeutic NNRTI concentrations in preclinical and clinical settings, paper presented at the 15th Conference on Retroviruses and Opportunistic Infections, Boston, MA, 3 to 7 February 2008.
147. T. C. Quinn, M. J.Wawer, N. Sewankambo, D. Serwadda, C. Li, F.Wabwire-Mangen, M. O. Meehan, T. Lutalo, R. H. Gray, Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group. N. Engl. J. Med. 342, 921-929 (2000).
148. J. M. Baeten, E. Kahle, J. R. Lingappa, R. W. Coombs, S. Delany-Moretlwe, E. Nakku-Joloba, N. R. Mugo, A. Wald, L. Corey, D. Donnell, M. S. Campbell, J. I. Mullins, C. Celum; Partners in Prevention HSV/HIV Transmission Study Team, Genital HIV-1 RNA predicts risk of heterosexual HIV-1 transmission. Sci. Transl. Med. 3, 77ra29 (2011).
149. P. M. Garcia, L. A. Kalish, J. Pitt, H. Minkoff, T. C. Quinn, S. K. Burchett, J. Kornegay, B. Jackson, J. Moye, C. Hanson, C. Zorrilla, J. F. Lew, Maternal levels of plasma human immunodeficiency virus type 1 RNA and the risk of perinatal transmission. Women and Infants Transmission Study Group. N. Engl. J. Med. 341, 394-402 (1999).
150. R. Becquet, D. K. Ekouevi, E. Arrivé, J. S. Stringer, N. Meda, M. L. Chaix, J. M. Treluyer, V. Leroy, C. Rouzioux, S. Blanche, F. Dabis, Universal antiretroviral therapy for pregnant and breastfeeding HIV-1-infected women: Towards the elimination of mother-to-child transmission of HIV-1 in resource-limited settings. Clin. Infect. Dis. 49, 1936-1945 (2009).